Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    4272516 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Levetiracetam Treatment of L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease
Intervention: Drug: Intravenous Levodopa
2 Completed EMD 128130 for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: EMD 128130;   Drug: IV Levodopa
3 Completed Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: NS2330;   Drug: Levodopa and Domperidone
4 Completed Study of LY300164 for the Treatment of Parkinson's Disease
Conditions: Dyskinesias;   Parkinson Disease
Intervention: Drug: LY300164
5 Completed Riluzole to Treat Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: IV Levodopa
6 Completed KW-6002 to Treat Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: KW-6002;   Drug: IV Levodopa
7 Completed Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Condition: Parkinson´s Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.